Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Efficacy of diet with low glycemic index in evaluating outcomes after stenting in ischemic heart disease

Breadcrumb

  • Home
  • Efficacy of diet with low glycemic index in evaluating outcomes after stenting in ischemic heart disease

Payziev Djamshid Djuravaevich *

Department of Internal Medicine, Nephrology and Hemodialysis, Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan.

Research Article

World Journal of Biology Pharmacy and Health Sciences, 2025, 22(02), 155-163

Article DOI: 10.30574/wjbphs.2025.22.2.0463

DOI url: https://doi.org/10.30574/wjbphs.2025.22.2.0463

Received on 25 March 2025; revised on 30 April 2025; accepted on 02 May 2025

Introduction. Nutritional intervention is a critical element of post-stenting cardiac rehabilitation. Among dietary strategies, low-carbohydrate regimens have emerged as a potentially beneficial approach for enhancing metabolic control and minimizing complications in patients with ischemic heart disease (IHD).

Objective. To evaluate the effects of a low-carbohydrate diet on lipid metabolism, systemic inflammation, and clinical outcomes following percutaneous coronary intervention (PCI).

Methods. A total of 108 post-stenting patients were enrolled and randomly assigned to either a low-carbohydrate diet group (n=54) or a standard diet group (n=54). Over a 12-month follow-up, assessments included lipid and glycemic profiles, inflammatory markers (C-reactive protein, interleukin-6, tumor necrosis factor-α), echocardiographic parameters, and incidence of major adverse cardiovascular events (MACE).

Results. Patients adhering to the low-carbohydrate diet showed significant reductions in triglycerides (−28.5%, p<0.001), low-density lipoprotein (−18.7%, p<0.05), fasting glucose (−9.3%, p<0.01), and insulin levels (−16.8%, p<0.001), with a concurrent rise in high-density lipoprotein (+15.2%, p<0.01). Inflammatory markers were significantly lower, which paralleled a reduced incidence of recurrent angina (7.4% vs. 15.8%, p=0.03), repeat revascularization (5.2% vs. 12.6%, p=0.02), and cardiovascular mortality (2.1% vs. 5.9%, p=0.04).

Conclusions. Implementation of a low-carbohydrate diet in post-PCI care enhances metabolic profiles, attenuates inflammation, and lowers the risk of adverse cardiovascular events, underscoring its utility as a key element in comprehensive cardiac rehabilitation.

Ischemic Heart Disease; Percutaneous Coronary Intervention; Low-Carbohydrate Diet; Lipid Metabolism; Inflammation; Secondary Prevention

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2025-0463.pdf

Preview Article PDF

Payziev Djamshid Djuravaevich. Efficacy of diet with low glycemic index in evaluating outcomes after stenting in ischemic heart disease. World Journal of Biology Pharmacy and Health Sciences, 2025, 22(02), 155-163. Article DOI: https://doi.org/10.30574/wjbphs.2025.22.2.0463

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution